Variant report

Variant	rs2575693
Chromosome Location	chr8:104387531-104387532
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:7)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:7 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr8:104387523-104388164	SK-N-SH	brain:	n/a	n/a
2	MAFK	chr8:104387439-104387706	HepG2	liver:	n/a	n/a
3	POLR2A	chr8:104387137-104388197	IMR90	lung:	n/a	n/a
4	MAFK	chr8:104387466-104387715	IMR90	lung:	n/a	n/a
5	MAFF	chr8:104387482-104387717	HepG2	liver:	n/a	n/a
6	MAFK	chr8:104387426-104387720	HepG2	liver:	n/a	n/a
7	POLR2A	chr8:104386234-104388294	SK-N-SH	brain:	n/a	n/a

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:104289531..104293502-chr8:104385386..104388063,3	MCF-7	breast:
2	chr8:104383486..104387596-chr8:104393672..104397600,4	K562	blood:
3	chr8:104382282..104385358-chr8:104387344..104390689,3	K562	blood:
4	chr8:104313517..104316996-chr8:104385407..104388642,4	MCF-7	breast:
5	chr8:104380544..104384762-chr8:104386449..104389451,3	K562	blood:
6	chr8:104384672..104387548-chr8:104409163..104411650,2	K562	blood:
7	chr8:104384922..104387635-chr8:104403443..104406734,3	MCF-7	breast:

No data

Variant related genes	Relation type
CTHRC1	TF binding region
ENSG00000207399	Chromatin interaction
ENSG00000266289	Chromatin interaction
ENSG00000164932	Chromatin interaction

Extended variants
information (count: 118 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:106)

rs_ID	r²[population]
rs1061195	0.83[ASN][1000 genomes]
rs1095723	0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1095725	0.91[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs11780843	0.91[AMR][1000 genomes];0.84[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs1370005	0.84[CHB][hapmap];0.84[JPT][hapmap]
rs1436595	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.83[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs1436597	0.81[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs1436598	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs1436599	1.00[CEU][hapmap];0.81[CHB][hapmap];0.86[JPT][hapmap];0.81[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs1865853	0.84[ASN][1000 genomes]
rs1865854	0.84[ASN][1000 genomes]
rs1865855	0.85[CHB][hapmap];0.80[JPT][hapmap]
rs2082971	0.83[ASN][1000 genomes]
rs2118057	0.96[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2241777	1.00[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs2241778	1.00[CEU][hapmap];0.81[CHB][hapmap];0.86[JPT][hapmap];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2304501	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs2388720	1.00[CEU][hapmap];0.81[CHB][hapmap];0.86[JPT][hapmap];0.81[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs2437762	0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2575691	1.00[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.96[YRI][hapmap];0.89[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2575692	1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes]
rs2575694	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2575697	0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2575699	0.90[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2687348	0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2687350	1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes]
rs2687359	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2687363	0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2687364	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2917549	0.96[ASN][1000 genomes]
rs2917551	0.87[ASN][1000 genomes]
rs2948446	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs2948452	0.95[ASN][1000 genomes]
rs3098214	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.82[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs3098215	0.90[CHB][hapmap];0.85[JPT][hapmap]
rs3098217	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3098218	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3098219	1.00[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];0.83[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs3098220	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs3098221	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3098222	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.96[YRI][hapmap];0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3098223	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.92[YRI][hapmap];0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3098224	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3098225	0.81[CHB][hapmap];0.85[JPT][hapmap]
rs3098227	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3098233	0.85[CHB][hapmap];0.85[JPT][hapmap];0.88[ASN][1000 genomes]
rs3098237	1.00[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];0.95[YRI][hapmap];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs3098240	0.85[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs3098241	0.90[CHB][hapmap];0.80[JPT][hapmap]
rs3098242	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs3098243	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap]
rs3098244	0.85[CHB][hapmap];0.80[JPT][hapmap]
rs3098248	0.81[ASN][1000 genomes]
rs3098249	0.85[CHB][hapmap];0.86[JPT][hapmap];0.96[YRI][hapmap];0.83[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs3098250	0.85[CHB][hapmap];0.86[JPT][hapmap];0.83[ASN][1000 genomes]
rs3098255	1.00[CEU][hapmap];0.81[CHB][hapmap];0.86[JPT][hapmap];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3098256	0.97[AMR][1000 genomes];0.93[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3098257	0.83[ASN][1000 genomes]
rs3098258	0.83[ASN][1000 genomes]
rs3098259	0.90[CHB][hapmap];0.85[JPT][hapmap];0.83[ASN][1000 genomes]
rs3098260	0.85[CHB][hapmap];0.80[JPT][hapmap];0.83[ASN][1000 genomes]
rs3133804	0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs3133807	0.83[ASN][1000 genomes]
rs3133809	0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3133811	0.82[ASN][1000 genomes]
rs3133813	0.90[CHB][hapmap];0.85[JPT][hapmap]
rs3133814	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs3133817	0.90[CHB][hapmap];0.85[JPT][hapmap]
rs3134253	0.81[CHB][hapmap];0.85[JPT][hapmap]
rs3134254	0.90[CHB][hapmap];0.80[JPT][hapmap]
rs3134258	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs3134261	0.81[CHB][hapmap];0.86[JPT][hapmap]
rs3134262	0.85[CHB][hapmap];0.80[JPT][hapmap]
rs3134264	0.85[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs3134266	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs3134267	0.88[CHB][hapmap];0.84[JPT][hapmap]
rs3134271	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3134272	0.83[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs3134273	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.92[YRI][hapmap];0.80[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs3134275	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3134277	0.85[CHB][hapmap];0.85[JPT][hapmap]
rs3134278	1.00[CEU][hapmap];0.81[CHB][hapmap];0.86[JPT][hapmap];0.96[YRI][hapmap];0.81[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs3134280	0.81[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs3134282	0.81[CHB][hapmap];0.85[JPT][hapmap]
rs3134285	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.96[YRI][hapmap];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs3134286	0.85[CHB][hapmap]
rs3134287	1.00[CEU][hapmap];0.89[CHB][hapmap];0.85[JPT][hapmap];0.95[YRI][hapmap];0.90[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs3134289	0.93[CEU][hapmap];0.89[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs3134290	1.00[CEU][hapmap];0.85[CHB][hapmap];0.86[JPT][hapmap];0.89[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs3134291	1.00[CEU][hapmap];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs3134292	0.90[CHB][hapmap];0.85[JPT][hapmap]
rs3134293	0.85[CHB][hapmap]
rs3134295	0.96[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs3134296	0.90[CHB][hapmap]
rs3134297	0.90[CHB][hapmap];0.85[JPT][hapmap]
rs4734699	0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4734700	0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs7009159	0.87[ASN][1000 genomes]
rs7465574	0.85[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs750606	0.90[CHB][hapmap];0.80[JPT][hapmap]
rs7816297	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs827592	0.83[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs827595	0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs844138	0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs893044	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs975440	0.85[CHB][hapmap];0.86[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv429931	chr8:104097396-104878014	Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
2	nsv1020476	chr8:104312212-104924482	Genic enhancers Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
3	nsv539704	chr8:104312212-104924482	Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Weak transcription Active TSS Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
4	nsv1016395	chr8:104327541-104473005	Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
5	nsv1023048	chr8:104355188-104872701	Flanking Active TSS Strong transcription Weak transcription Active TSS Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
6	nsv539705	chr8:104355188-104872701	ZNF genes & repeats Enhancers Strong transcription Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
7	nsv1021345	chr8:104361854-104879684	Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
8	nsv1032085	chr8:104362187-104878345	Active TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
9	nsv1033477	chr8:104369940-104439632	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
10	nsv539706	chr8:104369940-104439632	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
11	nsv1034183	chr8:104369940-104814008	Weak transcription Strong transcription Enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
12	nsv539707	chr8:104369940-104814008	Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Active TSS Bivalent/Poised TSS Enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs2575693	SLC25A32	cis	multi-tissue	Pritchard

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:104384200-104394800	Weak transcription	GM12878-XiMat	blood
2	chr8:104384200-104399800	Weak transcription	Primary T cells from cord blood	blood
3	chr8:104384400-104388000	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr8:104384400-104388000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr8:104384400-104412200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
6	chr8:104384600-104409400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr8:104384600-104418600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr8:104384800-104392600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
9	chr8:104385000-104399000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr8:104385000-104408800	Weak transcription	Fetal Muscle Trunk	muscle
11	chr8:104385000-104415600	Weak transcription	Placenta	Placenta
12	chr8:104385400-104388400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr8:104385400-104400400	Weak transcription	A549	lung
14	chr8:104385600-104389600	Weak transcription	Fetal Brain Male	brain
15	chr8:104385600-104399200	Weak transcription	Fetal Stomach	stomach
16	chr8:104385600-104399800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr8:104385600-104400200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr8:104385600-104400200	Weak transcription	Fetal Thymus	thymus
19	chr8:104385600-104400600	Weak transcription	Primary hematopoietic stem cells	blood
20	chr8:104385600-104405400	Weak transcription	Primary T cells fromperipheralblood	blood
21	chr8:104385600-104408400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr8:104385600-104423600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr8:104385600-104424600	Weak transcription	Cortex derived primary cultured neurospheres	brain
24	chr8:104385800-104393400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr8:104385800-104399800	Weak transcription	HUES6 Cell Line	embryonic stem cell
26	chr8:104385800-104409000	Weak transcription	Primary T helper cells PMA-I stimulated	--
27	chr8:104385800-104409000	Weak transcription	Stomach Smooth Muscle	stomach
28	chr8:104386000-104387600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr8:104386000-104388000	Weak transcription	HMEC	breast
30	chr8:104386000-104389000	Weak transcription	HSMM	muscle
31	chr8:104386000-104395600	Weak transcription	Placenta Amnion	Placenta Amnion
32	chr8:104386000-104399800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr8:104386000-104399800	Weak transcription	Fetal Muscle Leg	muscle
34	chr8:104386000-104400200	Weak transcription	Dnd41	blood
35	chr8:104386000-104400600	Weak transcription	Muscle Satellite Cultured Cells	--
36	chr8:104386000-104409800	Weak transcription	NHLF	lung
37	chr8:104386000-104418600	Weak transcription	Aorta	Aorta
38	chr8:104386000-104425600	Weak transcription	HSMMtube	muscle
39	chr8:104386200-104387600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
40	chr8:104386200-104388400	Weak transcription	NHEK	skin
41	chr8:104386200-104405600	Weak transcription	HUVEC	blood vessel
42	chr8:104386800-104388600	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr8:104387000-104387800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr8:104387000-104387800	Weak transcription	Small Intestine	intestine
45	chr8:104387000-104399800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr8:104387200-104387600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr8:104387200-104387800	Enhancers	NHDF-Ad	bronchial
48	chr8:104387200-104388200	Enhancers	H1 Cell Line	embryonic stem cell
49	chr8:104387200-104388200	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr8:104387200-104388200	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links